More Potent Antiplatelet Therapy in Acute Coronary Syndrome Patients With Prior Stroke: Proceed With Caution?

Mayo Clin Proc. 2023 Nov;98(11):1590-1592. doi: 10.1016/j.mayocp.2023.09.014.

Authors

Christopher M McKinnie¹, Mark B Effron²

Affiliations

¹ John Ochsner Heart and Vascular Institute, Ochsner Medical Center, New Orleans, LA.
² John Ochsner Heart and Vascular Institute, Ochsner Medical Center, New Orleans, LA; University of Queensland-Ochsner Clinical School, New Orleans, LA. Electronic address: mark.effron@ochsner.org.

PMID: 37923516
DOI: 10.1016/j.mayocp.2023.09.014

No abstract available

Publication types

Editorial
Comment

MeSH terms

Acute Coronary Syndrome* / complications
Acute Coronary Syndrome* / drug therapy
Health Services
Humans
Platelet Aggregation Inhibitors / adverse effects
Stroke* / chemically induced
Stroke* / drug therapy
Stroke* / prevention & control

Substances

Platelet Aggregation Inhibitors